2026-05-05 00:49:11
Latest Post
SNL Bearings Ltd Q4 FY2026 PAT at Rs. 2.57 crore
IIFL Capital Services Ltd reports Rs. 114.73 crores consolidated profit in Q4 FY2025-26
South West Pinnacle Exploration Ltd Q4 FY26 consolidated net profit rises to Rs. 13.04 crores
Computer Age Management Services Ltd Q4FY26 consolidated profit at Rs. 126.43 crores
Aarti Industries Ltd reports Rs. 137 crores consolidated profit in Q4FY26
Stock Report
Nath Bio-Genes India Ltd consolidated Q4FY26 loss at Rs. 1.50 crore
Posted On : 2026-05-04 22:54:48( TIMEZONE : IST )
Nath Bio-Genes (India) Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 51.5928 crores during the period ended March 31, 2026 as compared to Rs. 65.9590 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. -1.5076 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 1.6964 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. -0.79 for the period ended March 31, 2026 as compared to Rs. 0.89 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 51.5928 crs | ₹65.9590 crs |  -21.78% |
| Net Profit | ₹-1.5076 crs | ₹1.6964 crs | -188.87% |
| EPS | ₹-0.79 | ₹0.89 | -188.76% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 51.5928 crores during the period ended March 31, 2026 as compared to Rs.51.9677 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.-1.5076 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.0.7998 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.-0.79 for the period ended March 31, 2026 as compared to Rs.0.42 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 51.5928 crs | ₹51.9677 crs | -0.72% |
| Net Profit | ₹-1.5076 crs | ₹0.7998 crs | -288.50% |
| EPS | ₹-0.79 | ₹0.42 | -288.10% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.445.1015 crores during the Financial Year ended March 31, 2026 as compared to Rs.364.9082 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.39.8726 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.38.2693 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.20.98 for the Financial Year ended March 31, 2026 as compared to Rs.20.14 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹445.1015 crs | ₹364.9082 crs |  21.98% |
| Net Profit | ₹39.8726 crs | ₹38.2693 crs | 4.19% |
| EPS | ₹20.98 | ₹20.14 | 4.17% |
Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 189.35 as compared to the previous close of Rs. 196.00. The total number of shares traded during the day was 6589 in over 183 trades.
The stock hit an intraday high of Rs. 197.00 and intraday low of 188.00. The net turnover during the day was Rs. 1272405.00.
